The short answer
A coenzyme vs. a synthetic small molecule.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found naturally in every living cell, involved in fundamental cellular metabolic processes. 5-Amino 1MQ is a synthetic small-molecule compound studied in the literature as an inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme. They share no structural relationship — the comparison mostly comes up because both are commonly searched together in research-compound catalogs.
Classification comparison
| Attribute | NAD+ | 5-Amino 1MQ |
|---|---|---|
| Compound type | Naturally occurring coenzyme | Synthetic small molecule |
| Studied as | Cellular metabolic cofactor | NNMT enzyme inhibitor |
| DAAVY listing | NAD+, 1000 mg — COA7575 | 5-Amino 1MQ, 10 mg — COA7119 |
Reading the documentation for each
Because these are separate, unrelated products, each has its own independent Certificate of Analysis rather than a shared combined report. See our full COA guide for the general checklist to apply to either one, and our HPLC vs. LC-MS guide for what the stated test method tells you.
Frequently asked questions
Are NAD+ and 5-Amino 1MQ the same type of compound?
No. NAD+ is a naturally occurring coenzyme; 5-Amino 1MQ is a synthetic small molecule studied as an NNMT inhibitor. They're structurally unrelated.
Are they sold as separate products?
Yes — each has its own listing and its own COA (COA7575 for NAD+, COA7119 for 5-Amino 1MQ).
Which analytical method applies to each?
Both are commonly documented via HPLC and/or LC-MS. See our HPLC vs. LC-MS guide for what each method actually measures.